News
Consolidated sales amounted to €3,980 million in 2024, up 10.3% like-for-like from €3,675 million in the prior year period. Reported growth stood at +8.3% for the period.
Swipe to discover more
-
bioMérieux launches GENE-UP® TYPER, an innovative diagnostic solution for food industries to rapidly analyze the root cause of contamination of Listeria monocytogenes
bioMérieux, a world leader in the field of in vitro diagnostics, today announces the launch of GENE-UP® TYPER, a real-time PCR solution for rapid root cause analysis in the food industry. -
Clinical Informatics & Artificial Intelligence Can Help Advance Antimicrobial Stewardship
Worldwide escalation in antimicrobial resistance (AMR) has sparked fear of a looming post-antimicrobial era. Antibiotic overuse and inappropriate use—including over-prescribing, inaccurate, and suboptimal prescribing—promotes bacterial evolution and resistance to treatment. Data suggests that there were an estimated 4.95 million deaths associated with bacterial AMR in 2019. The World Bank estimates that AMR could result in 1 trillion dollars in additional healthcare costs by 2050 if actions are not taken now to curb growing resistance. -
bioMérieux and Vall d'Hebron Join Forces Against Infectious Diseases
bioMérieux announces a new strategic research partnership with Vall d'Hebron, one of Spain's largest and most prestigious healthcare institutions. This collaboration aims to advance research and development in the areas of infectious diseases, data surveillance, and laboratory automation.
Enabling Decision-Making
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19